Gland Pharma Limited has informed the Exchange regarding a press release dated Jun 04, 2025, titled "Gland Pharma receives approval from the United States Foodand Drug Administration (USFDA) for Angiotensin II Acetate Injection 2.5 mg/mL".
Gland Pharma Limited has informed the Exchange regarding a press release dated Jun 04, 2025, titled "Gland Pharma receives approval from the United States Foodand Drug Administration (USFDA) for Angiotensin II Acetate Injection 2.5 mg/mL".